Schedule 13G ownership disclosure

Vanda Pharmaceuticals Inc

Common Stock, par value $0.001 per share · CUSIP: 921659108

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Millennium Management LLC

    Shares: 1,679,013.00 · Class: 2.8%

  • Millennium Group Management LLC

    Shares: 1,679,013.00 · Class: 2.8%

  • Israel A. Englander

    Shares: 1,679,013.00 · Class: 2.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-26-002483
Form type
SCHEDULE 13G/A
Filer
MILLENNIUM MANAGEMENT LLC
CIK
CIK 1273087
Filed
Jan 09, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub